*** Plutos - Switzerland Fund Update *** SKAN - why less is more *** Sensirion - why more is more *** DocMorris - Once in a Lifetime *** Roche - Newsflow turns positive ***

*** Plutos - Switzerland Fund Update *** 'Looking through' H124? *** R&S Group increases investor traction *** Temenos back in the 'penalty box' ***

*** Plutos - Switzerland Fund Update *** Accelleron - the rock in the surf *** Komax - December as a low point *** Meyer Burger - Politics leaves the solar market to China *** SKAN - 'Reach and Raise'

*** Plutos - Switzerland Fund Update *** ams OSRAM as Apple's pawn *** Temenos: Attack of the Toothless *** OC Oerlikon - your focus needs more focus *** medmix: Value with Catalyst *** Bystronic's PMI Correlation***

*** Plutos - Switzerland Fund Update *** Meeting feedback: Accelleron, ams Osram, Cembra, Clariant, Comet DocMorris, Lonza, medmix, OC Oerlikon Rieter, SFS, SKAN, VAT *** Holcim: sensible spin-off * ** Pierer Mobility: Margin before growth ***

*** Plutos - Switzerland Fund Update *** Germania – quo vadis? *** Belimo with intact drivers *** Zehnder – demand finds ground ***

*** Plutos - Switzerland Fund Update *** Calida Group - at rock bottom *** Oerlikon's two faces *** Comet - modest euphoria *** Bucher - spurned quality *** R&S Group - the hidden champion in hyper

*** Plutos - Switzerland Fund Update *** Lonza - a stock market darling separates the ghosts *** Bystronic creates transparency *** Medartis - a story with hand and foot *** Sola's radar report ***

*** Plutos - Switzerland Fund Update *** 1st birthday of Plutos-Switzerland Fund *** German construction on the brink *** Tecan - fragile trust in the guidance *** Munich findings *** SFS - Solid as a rock ***

*** Plutos-Switzerland Fund Update *** DocMorris at the turning point *** Meyer Burger - Tour d'Horizon *** Pierer Mobility – from red to orange *** u-blox and the shortsightedness of the market *** SKAN - Under the radar